News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
25,280 Results
Type
Article (1140)
Company Profile (1)
Press Release (24139)
Section
Business (12291)
Career Advice (45)
Deals (1677)
Drug Development (1956)
FDA (395)
Job Trends (545)
News (15672)
Policy (781)
Tag
Academia (25)
Allergies (2)
Alliances (833)
ALS (1)
Alzheimer's disease (56)
Antibody-drug conjugate (ADC) (6)
Approvals (397)
Artificial intelligence (5)
Autoimmune disease (6)
Automation (1)
Bankruptcy (8)
Best Places to Work (465)
Biosimilars (4)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (15)
Cancer (127)
Cardiovascular disease (10)
Career advice (32)
CAR-T (4)
Cell therapy (6)
Cervical cancer (1)
Clinical research (1801)
Collaboration (14)
Compensation (39)
COVID-19 (44)
CRISPR (3)
C-suite (4)
Cystic fibrosis (3)
Data (193)
Depression (3)
Diabetes (12)
Diagnostics (231)
Digital health (1)
Drug discovery (1)
Duchenne muscular dystrophy (3)
Earnings (11967)
Editorial (1)
Events (2421)
Executive appointments (6)
FDA (557)
Frontotemporal dementia (1)
Funding (14)
Gene editing (4)
Gene therapy (4)
GLP-1 (20)
Government (88)
Guidances (128)
Healthcare (629)
HIV (2)
IgA nephropathy (4)
Immunology and inflammation (6)
Immuno-oncology (1)
Indications (5)
Infectious disease (48)
Inflammatory bowel disease (2)
Inflation Reduction Act (1)
Influenza (1)
Intellectual property (5)
Interviews (8)
IPO (1290)
Job creations (107)
Job search strategy (32)
JPM (2)
Kidney cancer (3)
Layoffs (5)
Legal (196)
Liver cancer (2)
Lung cancer (16)
Lymphoma (12)
Manufacturing (6)
MASH (1)
Medical device (541)
Medtech (546)
Mergers & acquisitions (402)
Metabolic disorders (19)
Multiple sclerosis (3)
NASH (2)
Neurodegenerative disease (8)
Neuropsychiatric disorders (8)
Neuroscience (86)
NextGen: Class of 2026 (123)
Non-profit (40)
Obesity (5)
Opinion (6)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (4)
Patents (5)
Patient recruitment (4)
Peanut (2)
People (656)
Pharmacy benefit managers (2)
Phase 1 (413)
Phase 2 (676)
Phase 3 (768)
Pipeline (514)
Postmarket research (86)
Preclinical (136)
Press Release (2)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (18)
Real estate (89)
Regulatory (549)
Reports (2)
Research institute (35)
Resumes & cover letters (7)
Rett syndrome (1)
RSV (2)
Schizophrenia (4)
Series A (2)
Series B (2)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (2)
Startups (75)
Vaccines (11)
Weight loss (7)
Women's health (2)
Date
Today (8)
Last 7 days (29)
Last 30 days (82)
Last 365 days (1350)
2026 (103)
2025 (1396)
2024 (1546)
2023 (1811)
2022 (2074)
2021 (1931)
2020 (1699)
2019 (1187)
2018 (923)
2017 (692)
2016 (442)
2015 (634)
2014 (486)
2013 (6635)
2012 (358)
2011 (457)
2010 (456)
Location
Africa (17)
Alabama (6)
Arizona (3)
Asia (1540)
Australia (156)
California (507)
Canada (99)
China (27)
Colorado (26)
Connecticut (25)
Delaware (17)
Europe (3474)
Florida (108)
Georgia (20)
Idaho (1)
Illinois (46)
India (2)
Indiana (31)
Iowa (1)
Japan (11)
Kansas (4)
Kentucky (4)
Louisiana (7)
Maine (4)
Maryland (69)
Massachusetts (361)
Michigan (22)
Minnesota (28)
Missouri (5)
Montana (2)
Nevada (3)
New Hampshire (7)
New Jersey (157)
New York (136)
North Carolina (54)
Northern California (265)
Ohio (12)
Pennsylvania (113)
South America (43)
Southern California (214)
Tennessee (5)
Texas (58)
United States (1876)
Utah (22)
Virginia (4)
Washington State (38)
Wisconsin (3)
25,280 Results for "142".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
December 8, 2025
·
5 min read
Press Releases
First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
December 19, 2025
·
6 min read
Press Releases
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
February 3, 2026
·
6 min read
Press Releases
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
December 18, 2025
·
7 min read
Press Releases
SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025
October 20, 2025
·
3 min read
Press Releases
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
November 5, 2025
·
6 min read
Press Releases
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
November 10, 2025
·
12 min read
Press Releases
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
November 4, 2025
·
3 min read
Press Releases
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
September 4, 2025
·
3 min read
Press Releases
Over the Counter (OTC) Drugs Market Size Hits USD 142.27 Billion in 2025, Rising Self-Medication Trends and AI-Driven Personalization
July 15, 2025
·
1 min read
1 of 2,528
Next
